GDS vs MANH

GDS exhibits stable financial health with a Piotroski F-Score of 6/9, yet it is fundamentally disconnected from its valuation benchmarks. The current price of $41.19 represents a massive premium over the Graham Number ($16.66) and the Intrinsic Value ($4.48), while a PEG ratio of 12.70 suggests extreme overvaluation relative to its 8.6% revenue growth. Despite a 'Strong Buy' analyst consensus, the technical trend is heavily bearish (10/100) and the forward P/E of 172.63 is unsustainable.

MANH exhibits strong fundamental health with a Piotroski F-Score of 7/9 and an exceptional ROE of 71.66%, though it lacks an Altman Z-Score for bankruptcy risk assessment. While the company has a stellar 25-quarter track record of earnings beats, the stock is currently in a severe technical downtrend, losing over 37% of its value in the last six months. The current price of $126.11 trades at a significant premium to both the Graham Number ($20.64) and the growth-based Intrinsic Value ($79.74). Despite a bullish analyst target of $208.55, the combination of slow revenue growth (5.7%) and bearish insider sentiment warrants a neutral stance until price stabilization occurs.